An integrated microfluidics platform with high-throughput single-cell cloning array and concentration gradient generator for efficient cancer drug effect screening.

Authors:
Wang B; He BS; Ruan XL; Zhu J; Hu R and 4 more

Journal:
Mil Med Res

Publication Year: 2022

DOI:
10.1186/s40779-022-00409-9

PMCID:
PMC9494811

PMID:
36131323

Journal Information

Full Title: Mil Med Res

Abbreviation: Mil Med Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Military Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis study was approved by the Committee on Human Research of Renmin Hospital of Wuhan University (WDRY2022-K021). Anticoagulant bone marrow specimens were obtained from surgery at Renmin Hospital of Wu Han University and delivered following standard protocol. All participants were given written informed consent to participate in the study. Consent for publicationNot applicable. Competing interestsThe authors declare that there are no competing interests. Competing interests The authors declare that there are no competing interests."

Evidence found in paper:

"Funding This study was funded by the financial supports from the National Natural Science Foundation of China (21904139)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025